The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.

A TODDLER given a “nightmare” diagnosis after catching a common childhood virus is asking Father Christmas for a life-saving heart transplant this Christmas. Little Willow Stansfield, ...

For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...

She highlighted that one in three adults is carrying the dormant virus: “Shingles typically comes to light when the body’s ...

The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...

Despite the effects of the condition on the body, many fans of the travel show would be unaware that the host is living with ...

The US Food and Drug Administration (FDA) has approved the first prescription medicine for adults with moderate-to-severe ...

The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...

Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in combination ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

Learn how amoxicillin works, its role in managing urinary tract infections, and when it may be the right antibiotic choice ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...